Abstract
The discovery of azaserine in culture filtrates of Streptomyces fragilis (Anderson et al., 1956) was announced by Ehrlich et al. (1954); and its inhibitory activity against Crocker Mouse Sarcoma 180 was described (Stock et al., 1954). 6-Diazo-5-oxo-L-norleucine(DON), produced by an unidentified Streptomyces, was discovered shortly thereafter (Ehrlich et al., 1956; Clark, Reilly and Stock, 1956). Azaserine occupies a unique position in the historical development of antibiotics: it is the first antibiotic whose discovery was the direct result of a systematic search for tumor-inhibiting antibiotics. Although equivocal clinical utility has been demonstrated against various malignancies, both of these antibiotics have proved to be valuable research tools and significant biochemical advances have resulted from their discovery.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Aaronson, S.: Mode of action of azaserine on Gaffkya homari. J. Bacteriol. 77, 548 (1959).
Abrams, R., and M. Bentley: Biosynthesis of nucleic acid purines. III. Guanosine 5′-phosphate formation from xanthosine 5′-phosphate and L-glutamine. Arch. Biochem. Biophys. 79, 91 (1959).
Ammann, C. A., and R. S. Safferman: The onion test as a possible screening method for antitumor agents. Antibiotics & Chemotherapy 8, 1 (1958).
Anderson, L. E., J. Ehrlich, S. H. Sun, and P. R. Burkholder: Strains of Streptomyces, the sources of azaserine, elaiomycin, griseoviridin, and viridogrisein. Antibiotics & Chemotherapy 6, 100 (1956).
Anderson, E. P., and L. W. Law: Biochemistry of cancer. Ann. Rev. Biochem. 29, 577 (1960).
Anderson, E. P., B. Levenberg, and L. W. Law: Purine biosynthesis in azaserine-sensitive and-resistant lines of the mouse plasma cell neoplasm 70429. Federation Proc. 16, 145 (1957).
Barclay, R. K., E. Garfinkel, and M. Phillipps: Effects of 6-diazo-5-oxo-L-norleucine on the incorporation of precursors into nucleic acids. Cancer Res. 22, 809 (1962).
Barg, W., E. Boggiano, N. Sloane, and E. C. Derenzo: Inhibitors of de novo formyl glycinamide ribotide synthesis in pigeon liver extracts. Federation Proc. 16, 150 (1957).
Barker, S.A., J. A. Bassham, M. Calvin, and U. A. Quark: Sites of azaserine inhibition during photosynthesis by Scenedesmus. J. Am. Chem. Soc. 78, 4632 (1956).
Benbadis, M. C.: Modality of the resumption of mitotic activity in the radicular meristem of Allium sativum after moderate treatment with azaserine; comparison with the action of triethylene melamine. Compt. Rend. Soc. Biol. 260, 268 (1965).
Bennett, Jr., L. L., F. M. Schabel, Jr., and H. E. Skipper: Studies on the mode of action of azaserine. Arch. Biochem. Biophys. 64, 423 (1956).
Brock, T. D., and M. L. Brock: Reversal of azaserine by phenylalanine. J. Bacteriol. 81, 212 (1961).
Brockman, R. W.: Mechanisms of resistance to anticancer agents. In: A. HADDOW and S. WEINHOUSE (eds.), Advances in cancer reseArch. vol. 7, p. 129. NewYork: Academic Press, Inc. 1963.
Brockman, R. W., and E. P. Anderson: Biochemical effects of duazomycin A in the plasma cell neoplasm 70429. Proc. Am. Assoc. Cancer Research 3, 307 (1962) (Abstract 32).
Buchanan, J. M.: The interference of azaserine in purine biosynthesis. In: G.E.W. WOLSTENHOLME and C. M. O’Connor (eds.), p. 75–88. Ciba foundation symposium on amino acids and peptides with antimetabolic activity. London: J. & A. Churchill, Ltd. 1958.
Burchenal, J. H., M. L. Murphy, and C. T. C. Tan: Treatment of acute leukemia. Pediatrics 18, 643 (1956).
Burchenal, J. H., M. L. Murphy, C. T. C. Tan, M. Yuceoglu, and D. A. Karnofsky: Combination therapy of acute leukemia with azaserine and mercaptopurine. Am. J. Diseases Children 90, 644 (1955).
Clarke, D. A., H. C. Reilly, and C. C. Stock: A comparative study of 6-diazo-5-oxo-L-norleucine and O-diazoacetyl-L-serine on Sarcoma 180. Antibiotics & Chemotherapy 7, 653 (1957).
Coffey, G. L., A. B. Hillegas, M. P. Knudsen, H. J. Koepsell, J. E. Oyaas, and J. Ehrlich: Azaserine: microbiological studies. Antibiotics & Chemotherapy 4, 775 (1954).
Crystal, M. M.: The induction of sexual sterility in the screwworm fly by antimetabolites and alkylating agents. J. Econ. Entomol. 56, 468 (1963).
Dagg, C. P., and D. A. Karnofsky: Teratogenic effects of azaserine on the chick embryo. J. Exptl. Zool. 130, 555 (1955).
Dawid, I.B., T. C. French, and J. M. Buchanan: Azaserine-reactive sulfhydryl group of 2-formamido-iV-ribosylacetamide-5′-phosphate: L-glutamine amido-ligase (adenosine diphosphate). II. Degradation of azaserine-C14-labeled enzyme. J. Biol. Chem. 238, 2178 (1963).
De Voe, S. E., N. E. Rigler, A. J. Shay, J. H. Martin, T. C. Boyd, E. J. Backus, J. H. Mowat, and N. Bohonos: Alazopeptin: production, isolation, and chemical characteristics. In: H. WELCH and F. MARTI-IBANEZ (eds.), Antibiotics annual, p. 730–735-NewYork: Medical Encyclopedia 1957.
Dion, H. W., S. A. Fusari, Z. L. Jakubowski, J. G. Zora, and Q. R. Bartz: 6-Diazo-5-oxo-L-norleucine, a new tumor-inhibitory substance. II. Isolation and characterization. J. Am. Chem. Soc. 78, 3075 (1956).
Duval, L. R.: New agent data summaries: azaserine. Cancer Chemoth. Rept. 7, 65 (1960a).
Duval, L. R.: New agent data summaries: 6-diazo-5-oxo-L-norleucine. Cancer Chemoth. Rept. 7, 86 (1960b).
Ehrlich, J., L. E. Anderson, G. L. Coffey, A. B. Hillegas, M. P. Knudsen, H. J. Koepsell, D. L. Kohberger, and J. E. Oyaas: Antibiotic studies of azaserine. Nature 173, 72 (1954).
Ehrlich, J., G. L. Coffey, M. W. Fisher, A. B. Hillegas, D. L. Kohberger, H. E. Machamer, W. A. Rightsel, and F. R. Roegner: 6-Diazo-5-oxo-L-norleucine, a new tumor inhibitory substance. Antibiotics & Chemotherapy 6, 487 (1956).
Fernandes, J. F., G. A. Le Page, and A. Lindner: The influence of azaserine and 6-mercaptopurine on the in vivo metabolism of ascites tumor cells. Cancer Research 16, 154 (1956).
French, T. C., I. B. Dawid, and J. M. Buchanan: Azaserine reactive sulfhydryl group of 2-formamido-iV-ribosylacetamide 5′-phosphate: L-glutamine amido-ligase (adenosine diphosphate). III. Comparison of degradation products with synthetic compounds. J. Biol. Chem. 238, 2186 (1963).
French, T. C., I. B. Dawid, R. A. Day, and J. M. Buchanan: Azaserine-reactive sulfhydryl group of 2-formamido-N-ribosylacetamide 5′-phosphate: L-glutamine amido-ligase (adenosine diphosphate). I. Purification and properties of the enzyme from Salmonella typhimurium and the synthesis of L-azaserine-C14. J. Biol. Chem. 238, 2171 (1963).
Friedman, M. H.: The effect of O-diazoacetyl-L-serine (azaserine) on the pregnancy of the dog; a preliminary report. J. Am. Vet. Med. Assoc. 130, 159 (1957).
Fusari, S. A., R. P. Frohardt, A. Ryder, T. H. Haskell, D. W. Johannessen, C. C. Elder, and Q. R. Bartz: Azaserine, a new tumor-inhibitory substance. Isolation and characterization. J. Am. Chem. Soc. 76, 2878 (1954a).
Fusari, S. A., T. H. Haskell, R. B. Frohardt, and Q. R. Bartz: Azaserine, a new tumor-inhibitory substance. Structural studies. J. Am. Chem. Soc. 76, 2881 (1954b).
Goldthwait, D. A.: 5-Phosphoribosylamine, a precursor of glycinamide ribotide. J. Biol. Chem. 222, 1051 (1956).
Gots, J. S., and E. G. Gollub: Purine metabolism in bacteria. IV. L-azaserine as an inhibitor. J. Bacteriol. 72, 858 (1956).
Greenlees, J., and G. A. Le Page: Purine biosynthesis and inhibitors in ascites cell tumors. Cancer Research 16, 808 (1956).
Griswold, D. P., W. R. Laster, Jr., M. Y. Snow, F. M. Schabel, Jr., and H. E. Skipper: Experimental evaluation of potential anticancer agents. XII. Quantitative drug response of SA 180, Ca 75 5, and leukemia L 1210 systems to a standard list of active and inactive agents. Cancer ReseArch. Suppl. (part. 2), 23(4), 271 (1963).
Grosch, D. S.: Insect fecundity and fertility: chemically induced decrease. Science 141, 732 (1963).
Harris J. J. The effect of NSC survey compounds on human tumors in embryonated eggs. Cancer ReseArch. Suppl. part 2 221 1 1962
Hartman, S. C.: Glutamine-phosphoribosyl pyrophosphate amidotransferase (GPA). Federation Proc. 21, 244 (1962).
Hartman, S. C., B. Levenberg, and J. M. Buchanan: Involvement of ATP, 5-phosphoribosylpyrophosphate and L-azaserine in the enzymatic formation of glycinamide ribotide intermediates in inosinic acid biosynthesis. J. Am. Chem. Soc. 77, 501 (1955).
Hedegaard, J., S. Maspero-Segre, N. V. Thoai, and J. Roche: Influence of histidine and its metabolites on biosynthesis of purines by Escherichia coli B. IV. Action on cultures inhibited by azaserine. Compt. Rend. Soc. Biol. 153, 767 (1959a).
Hedegaard, J., S. Maspero-Segre, N. V. Thoai, and J. Roche: Influences of histidine and its metabolites on biosynthesis of purines by Escherichia coli B. V. Mode of action in cultures inhibited by azaserine. Compt. Rend. Soc. Biol. 153, 954 (1959b).
Hedegaard, J., N. V. Thoai, and J. Roche: The influence of histidine on the biosynthesis of purines in Escherichia coli. Arch. Biochem. Biophys. 83, 183 (1959).
Henderson, J. R., and I. G. Funga: Inhibition of ascites tumor growth by 4-aminopyrazolo[3, 4-d]pyrimidine in combination with azaserine, 6-mercaptopurine, and thioguanine. Cancer Research 20, 1618 (1960).
Henderson, J. R., and I. G. Funga: Treatment of ascites tumors with 4-aminopyrazolo[3, 4-d]pyrimidine alone and in combination with azaserine, thioguanine, and 6-mercaptopurine. Cancer Research (part 2), 21(3), 7 (1961).
Hutchison, D. J.: Cross resistance and collateral sensitivity studies in cancer chemotherapy. In: A. HADDOW and S. WEINHOUSE (eds.), Advances in cancer reseArch. vol. 7, p. 235. NewYork: Academic Press, Inc. 1963.
Hutchison, D. J., D. L. Robinson, D. Martin, O. L. Ittensohn, and J. Dillenberg: Effects of selected cancer chemotherapeutic drugs on the survival times of mice with L1210 leukemia: relative responses of antimetabolite-resistant strains. Cancer ReseArch. Suppl., (part 2), 22(1), 57 (1962).
Iyer, V. N., and W. Szybalski: Mechanism of chemical mutagenesis. I. Kinetic studies on the action of triethylene melamine (TEM) and azaserine. Proc. Natl. Acad. Sci. U.S. 44, 446 (1958).
Iyer, V. N., and W. Szybalski: Mutagenic effect of azaserine in relation to azaserine resistance in E. coli. Science 129, 839 (1959).
Jacquez, J. A.: Active transport of O-diazoacetyl-L-serine and 6-diazo-5-oxo-L-norleucine in Ehrlich ascites carcinoma. Cancer Research 17, 890 (1957).
Jacquez, J. A.: Concentrative uptake of 6-diazo-5-oxo-L-norleucine by sarcoma 180, liver and muscle in vivo. Proc. Soc. Exptl. Biol. Med. 99, 611 (1958).
Jacquez, J. A., and J. H. Sherman: Enzymatic degradation of azaserine. Cancer Research 22(1), 56 (1962).
Jaffre, J. J.: In vivo activity of L-azaserine against Trypanosoma equiperdum. J. Protozool. 10, 340 (1963).
Johnson, I. S., L. A. Baker, and H. F. Wright: Possible utility of the Rous Sarcoma for antitumor screening. Ann. N.Y. Acad. Sci. 76, 861 (1958).
Kaplan, L., H. C. Reilly, and C. C. Stock: Action of azaserine on Escherichia coli. J. Bacteriol. 78, 511 (1959).
Kaplan, L., and C. C. Stock: Azaserine, an inhibitor of amino acid synthesis in Escherichia coli. Federation Proc. 13, 239 (1954).
Karnofsky, D. A., and C. R. Lacon: Survey of cancer chemotherapy service center compounds for teratogenic effect in the chick embryo. Cancer ReseArch. Suppl. (part 2), 22(1), 84 (1962).
Kohberger, D. L., H. C REILLY, G. L. Coffey, A. B. Hillegas, and J. Ehrlich: Azaserine assay with Kloeckera brevis. Antibiotics & Chemotherapy 5(2), 59 (1955).
Langan, T. A., N. O. Kaplan, and L. Shuster: Formation of the nicotinic acid analogue of diphosphopyridine nucleotide after nicotinamide administration. J. Biol. Chem. 234, 2161 (1959).
Lee, K. H., and Y. Yuzuriha: Studies on cell growth and cell division III. Action of azaserine on cell division. J. Pharm. Sci. 53, 290 (1964).
Lee, K. H., Y. O. Yuzuriha, and J. J. Eiler: Studies on cell growth and cell division. II. Selective activity of chloramphenicol and azaserine on cell growth and cell division. J. Am. Pharm. Assoc. 48, 470 (1959).
Le Page, G. A., and N. Howard: Chemotherapy studies of mammary tumors of C3H mice. Cancer Research 23, 622 (1963).
Levenberg, B., I. Melnick, and J. M. Buchanan: Biosynthesis of the purines. XV. The effect of aza-L-serine and 6-diazo-5-oxo-L-norleucine on inosinic acid biosynthesis de novo. J. Biol. Chem. 225, 163 (1957).
Loustalot, P., P. A. Desaulles, and R. Meier: Characterization of the specificity of action of tumor-inhibiting compounds. Ann. N.Y. Acad. Sci. 76, 838 (1958).
Maxwell, R. E., and V. S. Nickel: Filament formation in Escherichia coli induced by azaserine and other antineoplastic agents. Science 120, 270 (1954).
Maxwell, R. E., and V. S. Nickel: 6-Diazo-5-oxo-L-norleucine, a new tumor inhibitory substance. V. Microbiologic studies of mode of action. Antibiotics & Chemotherapy 7, 81 (1957).
Mccarthy, D. A., A. Bayles, and P. E. Thompson: The effect of azaserine against Plasmodium lophurae in chicks and attempts to antagonize this effect with metabolites. J. Parasitol. 43, 283 (1957).
Mercker, P. C., P. Anido, J. Sarino, and G. W. Woolley: A study of human epidermoid carcinoma (H.Ep. No. 3) growing in conditioned Swiss mice. III. Chemotherapy with selected chemicals and observations on diet, food intake, and drug toxicities. Cancer ReseArch. Suppl. (part 2) 22(1), 9 (1962). VAN DER MEULEN, P. Y. F., and J. A. Bassham: Study of inhibition of azaserine and diazoöxonorleucine (DON) on the algae Scenedesmus and Chlorella. J. Am. Chem. Soc. 81, 2233 (1959).
Moore, E. C., and R. B. Hurlbert: Biosynthesis of ribonucleic acid (RNA), cytosine, and RNA purines: differential inhibition by diazoöxonorleucine. Cancer Research 21, 257 (1961).
Murphy, M. L., and D. A. Karnofsky: Effect of azaserine and other growth-inhibiting agents on fetal development of the rat. Cancer 9, 955 (1962).
Nakamura, M.: Amoebicidal action of azaserine. Nature 178, 1119 (1956).
Narrates, A. J., and R. F. Pittillo: Inhibition of nonproliferating Escherichia coli by azaserine. In: J. C. SYLVESTER (ed.), p. 439–446, Antimicrobial agents and chemotherapy, 1963. Ann Arbor: Braum-Brumfield, Inc. American Society for Microbiology 1964.
Norman, A. G.: Inhibition of root growth by azaserine. Science 121, 213 (1955).
Norman, A. G.: Inhibition of root growth and cation uptake by antibiotics. Soil Sci. Soc. Am. Proc. 23, 368 (1959).
Patterson, E. L., B. L. Johnson, S. E. Devoe, and N. Bohonos: Structure of the antitumor antibiotic alazopeptin (Abstract 38), p. 18. In: Abstracts of papers presented at the fifth interscience conference on antimicrobial agents and chemotherapy 1965.
Pittillo, R. F.: Studies on the antimicrobial nature of action of azaserine. In: P. Gray, B. TABENKIN and S. G. BRADLEY (eds.), Antimicrobial agents annual, p. 276–287, 1960. NewYork: Plenum Press 1961.
Pittillo, R. F., A. J. Narrates, and J. Burns: Microbiological evaluation of 1, 3-bis (2-chloroethyl)-1-nitrosourea. Cancer Res. 24, 1222 (1964).
Pittillo, R. F., and B. G. Quinnelly: Further studies on the antimicrobial nature of action of azaserine. In: M. FINLAND and G. M. SAVAGE (eds.), Antimicrobial agents and chemotherapy, p. 245–253, 1961. Detroit: American Society for Microbiology 1962.
Potter, M., and L. W. Law: Studies of a plasma cell neoplasm of the mouse. I. Characterization of neoplasm 70429, including its sensitivity to various antimetabolites with the rapid development of resistance to azaserine, DON, and N-methyl formamide. J. Natl. Cancer Inst. 18, 413 (1957).
Preisler, O.: Effect of cytostatic agents on the genital development of rabbits. Arch. Gynäkol. 192, 501 (1960).
Preiss, J., and P. Handler: Biosynthesis of disphosphopyridine nucleotide. II. Enzymatic aspects. J. Biol. Chem. 233, 493 (1958).
Rao, K. V.: Chemistry of the duazomycins. I. Duazomycins A. In: M. FINLAND and G. M. SAVAGE (eds.), Antimicrobial agents and chemotherapy, 1961, p. 178–183. Detroit: American Society for Microbiology 1962.
Rao, K. V., S. C. Brooks, Jr., M. Kugelman, and A. A. Romano: Duazomycins A, B, and C., three antitumor substances. I. Isolation and characterization. In: H. WELCH and F. MARTI-IBANEZ (eds.), Antibiotics annual, p. 943–948. NewYork: Medical Encyclopedia 1960.
Reilly, H. C.: Inactivation of azaserine by a liver enzyme. Federation Proc. 13, 279 (1954a).
Reilly, H. C.: The effect of amino acids upon the antimicrobial activity of azaserine. Proc. Am. Assoc. Cancer Res. 1, 40 (1954b).
Reilly, H. C.: Effect of test medium upon the demonstration of antimicrobial activities of certain antibiotics. Bacteriol. Proc. 9, 72 (1956).
Reilly, H. C.: Some aspects of azaserine, 6-diazo-5-oxo-L-norleucine and β-2-Thienylalanine. In: G. E. W. WOLSTENHOLME and C. M. O’Connor (eds.), Ciba foundation symposium on amino acids and peptides with antimetabolic activity, p. 62–74. London: J. and. A. Churchill, Ltd. 1958.
Rivera, A., and P. R. Srinivasan: 3-Enolpyruvylshikimate 5-phosphate, an intermediate in the biosynthesis of anthranilate. Proc. Natl. Acad. Sci. U.S. 48, 864 (1962).
Sartorelli, A. C., and B. A. Booth: Comparative studies on the in vivo action of 6-chloropurine, 6-chloropurine ribonucleoside, and 6-chloro-9-ethylpurine on sarcoma 180 ascites cells. J. Parmacol. Exptl. Ther. 134, 123 (1961).
Sartorelli, A.C., and B. A. Booth: Some factors affecting the tumor-inhibitory properties of combinations of azaserine and 6-chloropurine. Biochem. Pharmacol. 12, 847 (1963).
Sartorelli, A. C., and G. A. Le Page: Inhibition of ascites cell growth by combinations of 6-thioguanine and azaserine. Cancer Res. 18, 938 (1958).
Skipper, H. E.: Perspectives in cancer chemotherapy: therapeutic design. Cancer Res. 24,(8), 1295 (1964).
Srinivasan, P. R.: Enzymatic synthesis of anthranilic acid from shikimic acid 5-phosphate and L-glutamine. J. Am. Chem. Soc. 81, 1772 (1959).
Srinivasan, P. R., and B. Weiss: The biosynthesis of-amino-benzoic acid: studies on the origin of the amino group. Biochem. Biophys. Acta 51, 597 (1961).
Stock, C. C., H. C. Reilly, S. M. Buckley, D. A. Clarke, and C. P. Rhoads: Azaserine, a new tumor inhibitory substance: studies with Crocker mouse sarcoma 180. Nature 173, 71 (1954).
Sugiura, K.: Studies in a spectrum of mouse, rat, and hamster tumors. Cancer Res., Suppl. (part 2) 22(1), 93 (1962).
Tarnowski, G. S., and C. C. Stock: Effects of combinations of azaserine and 6-diazo-5-oxo-L-norleucine with purine analogs and other antimetabolites on the growth of two mouse mammary carcinomas. Cancer Res. 17, 1033 (1957).
Teller, M. N.: Chemotherapy of transplantable human tumors in the rat. Cancer Res., Suppl. (part 2) 22(1), 25 (1962).
Thiersch, J. B.: Effect of O-diazo acetyl-L-serine on rat litter. Proc. Soc. Exptl. Biol. Med. 94, 27 (1957a).
Thiersch, J. B.: Effect of 6-diazo-5-oxo-L-norleucine (DON) on the rat litter in utero. Proc. Soc. Exptl. Biol. Med. 94, 33 (1957b).
Tomisek, A. J., H. J. Kelly, and H. E. Skipper: Chromatographic studies of purine metabolism. I. The effect of azaserine on purine biosynthesis in E. coli using various C14-labeled precursors. Arch. Biochem. Biophys. 64(2), 437 (1956).
Tomisek, A., M. R. Reid, W. A. Short, and H. E. Skipper: Studies on the photosynthetic reaction. III. The effects of various inhibitors upon growth and carbonatefixation in Chlorella pyrenoidosa. Plant Physiol. 32, 7 (1957).
Tomisek, A. J., M. R. Reid, and H. E. Skipper: Chromatographic studies of purine metabolism. IV. Reversal of azaserine-induced inhibition by phenylalanine and tryptophan. Cancer Res. 19, 489 (1959).
Truhant, R., and G. Deysson: Use of the plant cell as test object for the control of cancer by application of radiomimetics. Bull, assoc. franç, étude cancer. 44, 221 (1957).
Wheeler, G. P., F. M. Schabel, Jr., and H. E. Skipper: Potentiated inhibition of Escherichia coli by certain combinations of agents. Proc. Soc. Exptl. Biol. Med. 92, 396 (1956).
Woolley, G. W.: Chemotherapy of transplantable human tumors in the hamster. Cancer Res., Suppl. (part 2), 22(1), 34 (1962).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1967 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Pittillo, R.F., Hunt, D.E. (1967). Azaserine and 6-Diazo-5-Oxo-L-Norleucine (DON). In: Gottlieb, D., Shaw, P.D. (eds) Mechanism of Action. Antibiotics, vol 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-46051-7_39
Download citation
DOI: https://doi.org/10.1007/978-3-642-46051-7_39
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-46053-1
Online ISBN: 978-3-642-46051-7
eBook Packages: Springer Book Archive